We are live on
!
Find out more
EP
Eversept Partners Portfolio holdings
AUM
$1.93B
Turnover
41.06%
1-Year Est. Return
160.8%
This Fund
S&P 500
This Quarter
Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
(-1.2%)
Cap. Flow
+$35M
Cap. Flow
% of AUM
2.96%
Top 10 Holdings %
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
0.9
years
Top 20 Avg Time Held Equity + Options
1.1
years
Avg Time Held Equity only
1.5
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$27.9M |
| 2 |
HealthEquity
HQY
|
+$22.9M |
| 3 |
Shockwave Medical, Inc. Common Stock
SWAV
|
+$15.2M |
| 4 |
GSK
GSK
|
+$13.4M |
| 5 |
2seventy bio
TSVT
|
+$9.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$29M |
| 2 |
CATALENT, INC.
CTLT
|
+$15.5M |
| 3 |
Icon
ICLR
|
+$12.8M |
| 4 |
ABCM
Abcam PLC
ABCM
|
+$12.2M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.1% |
| 2 | Miscellaneous | 23.9% |
| 3 | Communication Services | 0% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
ARS Pharmaceuticals
SPRY
$400M
| – | – |
-48,788
| Closed | -$327K | – |
|
77
UroGen Pharma
URGN
$1.69B
| – | – |
-74,797
| Closed | -$774K | – |
|
78
Xenon Pharmaceuticals
XENE
$3.24B
| – | – |
-171,378
| Closed | -$6.6M | – |
|
79
Zai Lab
ZLAB
$2.6B
| – | – |
-55,176
| Closed | -$1.53M | – |
|
|
80
DELISTED
CATALENT, INC.
CTLT
| – | – |
-356,875
| Closed | -$15.5M | – |
|
81
DELISTED
MODEL N, INC.
MODN
| – | – |
-223,168
| Closed | -$7.89M | – |
|
|
ABCM
82
DELISTED
Abcam PLC
ABCM
| – | – |
-499,394
| Closed | -$12.2M | – |
|
|
PRTK
83
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| – | – |
-1,327,857
| Closed | -$2.93M | – |
|
Similar funds
SWM
RIA
SI
SG
DCP
SI
MFM
FWP
Eversept Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.
- Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
- Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
- Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
- Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
- Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
- Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
- Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.
Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.